Associations of Circadian and Metabolic Syndromes with Cardiovascular Diseases and Diabetes in Qatar: A Cross-Sectional Study.

IF 3 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Shahd Hamran, Omar Altrmanini, Mhd Osama Rahhal, Raneem Alsheikh, Iman Amro, Giridhara Rathnaiah Babu, Muhammad Naseem Khan, Habib Hasan Farooqui, Tawanda Chivese, Salma M Khaled
{"title":"Associations of Circadian and Metabolic Syndromes with Cardiovascular Diseases and Diabetes in Qatar: A Cross-Sectional Study.","authors":"Shahd Hamran, Omar Altrmanini, Mhd Osama Rahhal, Raneem Alsheikh, Iman Amro, Giridhara Rathnaiah Babu, Muhammad Naseem Khan, Habib Hasan Farooqui, Tawanda Chivese, Salma M Khaled","doi":"10.2147/DMSO.S503143","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Metabolic syndrome (MetS) increases the risk of cardiovascular diseases (CVDs). A combination of MetS with Circadian rhythm disorder (CRD) may be a stronger risk factor for CVDs than MetS alone. We conducted a nationally representative cross-sectional study to compare the associations of CRD and MetS with type 2 diabetes (T2DM) and CVDs in Qatar.</p><p><strong>Methods: </strong>Sociodemographic and health information were collected. MetS status was determined based on standard international criteria. CRD was defined based on either i) short sleep duration (≤ 6 hours per night) and MetS or (ii) short sleep duration, self-reported depression (or PHQ-2 score ≥ 3) and two components of MetS.</p><p><strong>Results: </strong>A total of 2523 respondents completed the interview, with a mean age of 37.1 years (SD = 11.2), women (n=637, 27.3%), and Qataris (n=754, 32.3%). The overall prevalence of MetS and CRD was 6.8% (95% CI: 5.4-8.5) and 2.4% (95% CI: 1.7-3.4), respectively; MetS was more prevalent in men (7.0%) compared to women (5.8%); the opposite was true for CRD (women 4.4% vs men 2.4%). Older age was a predictor of both MetS and CRD. Compared to Qataris, blue-collar expatriates had lower odds of MetS (OR = 0.32, 95% CI 0.23-0.58) and CRD (OR = 0.46, 95% CI: 0.20-1.05). Current married status was positively associated with MetS, but not CRD. Both MetS (OR=19.08, 95% CI: 10.87-33.50) and CRD (OR=10.32, 95% CI: 4.60-23.17) were strongly associated with T2DM. Similarly, MetS (OR = 5.51, 95% CI: 2.33-13.03) and CRD (OR = 2.01, 95% CI: 0.92-4.42) were associated with CVDs.</p><p><strong>Conclusion: </strong>MetS showed potentially stronger associations than CRD with T2DM and CVDs in Qatar. Further research is needed into the predictive utility of CRD compared with MetS for these outcomes in different populations including the Middle East.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"3259-3269"},"PeriodicalIF":3.0000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417713/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S503143","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Metabolic syndrome (MetS) increases the risk of cardiovascular diseases (CVDs). A combination of MetS with Circadian rhythm disorder (CRD) may be a stronger risk factor for CVDs than MetS alone. We conducted a nationally representative cross-sectional study to compare the associations of CRD and MetS with type 2 diabetes (T2DM) and CVDs in Qatar.

Methods: Sociodemographic and health information were collected. MetS status was determined based on standard international criteria. CRD was defined based on either i) short sleep duration (≤ 6 hours per night) and MetS or (ii) short sleep duration, self-reported depression (or PHQ-2 score ≥ 3) and two components of MetS.

Results: A total of 2523 respondents completed the interview, with a mean age of 37.1 years (SD = 11.2), women (n=637, 27.3%), and Qataris (n=754, 32.3%). The overall prevalence of MetS and CRD was 6.8% (95% CI: 5.4-8.5) and 2.4% (95% CI: 1.7-3.4), respectively; MetS was more prevalent in men (7.0%) compared to women (5.8%); the opposite was true for CRD (women 4.4% vs men 2.4%). Older age was a predictor of both MetS and CRD. Compared to Qataris, blue-collar expatriates had lower odds of MetS (OR = 0.32, 95% CI 0.23-0.58) and CRD (OR = 0.46, 95% CI: 0.20-1.05). Current married status was positively associated with MetS, but not CRD. Both MetS (OR=19.08, 95% CI: 10.87-33.50) and CRD (OR=10.32, 95% CI: 4.60-23.17) were strongly associated with T2DM. Similarly, MetS (OR = 5.51, 95% CI: 2.33-13.03) and CRD (OR = 2.01, 95% CI: 0.92-4.42) were associated with CVDs.

Conclusion: MetS showed potentially stronger associations than CRD with T2DM and CVDs in Qatar. Further research is needed into the predictive utility of CRD compared with MetS for these outcomes in different populations including the Middle East.

Abstract Image

Abstract Image

卡塔尔昼夜节律和代谢综合征与心血管疾病和糖尿病的关联:一项横断面研究
目的:代谢综合征(MetS)增加心血管疾病(cvd)的风险。代谢障碍合并昼夜节律障碍(CRD)可能是cvd的一个更强的危险因素。我们在卡塔尔进行了一项具有全国代表性的横断面研究,比较了CRD和MetS与2型糖尿病(T2DM)和cvd的关系。方法:收集社会人口学和健康信息。MetS状态是根据标准国际标准确定的。CRD的定义基于i)短睡眠时间(每晚≤6小时)和MetS或(ii)短睡眠时间、自我报告的抑郁(或PHQ-2评分≥3)和MetS的两个组成部分。结果:共有2523名受访者完成了访谈,平均年龄为37.1岁(SD = 11.2),女性(n=637, 27.3%),卡塔尔人(n=754, 32.3%)。met和CRD的总患病率分别为6.8% (95% CI: 5.4-8.5)和2.4% (95% CI: 1.7-3.4);MetS在男性(7.0%)中比女性(5.8%)更为普遍;CRD的情况正好相反(女性4.4%,男性2.4%)。年龄是met和CRD的预测因子。与卡塔尔人相比,蓝领外籍人士患MetS (OR = 0.32, 95% CI 0.23-0.58)和CRD (OR = 0.46, 95% CI: 0.20-1.05)的几率较低。目前的婚姻状况与met呈正相关,但与CRD无关。met (OR=19.08, 95% CI: 10.87-33.50)和CRD (OR=10.32, 95% CI: 4.60-23.17)与T2DM密切相关。同样,MetS (OR = 5.51, 95% CI: 2.33-13.03)和CRD (OR = 2.01, 95% CI: 0.92-4.42)与cvd相关。结论:在卡塔尔,MetS与T2DM和cvd的潜在关联强于CRD。在包括中东地区在内的不同人群中,需要进一步研究CRD与MetS对这些结果的预测效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信